跳至主要内容
临床试验/DRKS00001149
DRKS00001149招募中不适用

Measurement of adhesion molecules (sVCAM, SICAM, sE-selectin) in pediatric patients with lung failure

niversitätsklinikum FreiburgZentrum für Kinderheilkunde und Jugendmedizin0 个研究点目标入组 26 人开始时间: 2011年12月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
1 Years 至 15 Years(—)
性别
All

入选标准

  • age 1 - 15 years
  • intubation or NIV
  • paO2 / Fio2 < 300 (> 3 hours)
  • arterial line

排除标准

  • Vitium cordis
  • bone marrow transplantation (or intended)
  • planned surgical intervention during study period

研究者

发起方
niversitätsklinikum FreiburgZentrum für Kinderheilkunde und Jugendmedizin

相似试验

已完成
不适用
Comparison of Adhesion molecules before and after of streptokinase infusion in patients with acute MIAcute MI.Acute transmural myocardial infarction of anterior wall
IRCT138812122337N1Research center of Iran University of Medical Sciences40
已完成
3 期
Evaluation of adhesions formation using conventional third generation endometrial ablation with and without postoperative application of an intrauterine adhesion barrier filmIntra-uterine adhesions10062915
NL-OMON51498Catharina-ziekenhuis20
已完成
1 期
An interventional study to evaluate the effects of formulation on the Pharmacokinetics (PK, the measure of how the human body processes a substance) and adhesion (how well the patch sticks to the skin) of two Donepezil Transdermal Delivery System (TDS, a patch that delivers a drug) formulations, worn for seven days, applied to the backs of healthy participants.Alzheimer's Disease
ACTRN12616000836437INCResearch Australia Pty Ltd86
已完成
1 期
A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy ParticipantsHealthy
NCT02608320Janssen Research & Development, LLC52
进行中(未招募)
不适用
Evaluation of drug adhesion and foot care of Diabetic patients under pharmacist orientatioDiabetes mellitus type 2, diabetic footC14.907.320.191
RBR-972497niversidade Federal de Pernambuco